(4S)-(1-benzyloxycarbonyl)-3-tert-butoxycarbonyl-4-(2-hydroxyethyl)imidazolidine

Base Information

Chemical Name:(4S)-(1-benzyloxycarbonyl)-3-tert-butoxycarbonyl-4-(2-hydroxyethyl)imidazolidine
CAS No.:1000806-63-2
Molecular Formula:C₁₈H₂₆N₂O₅
Molecular Weight:350.415
Hs Code.:

Synonyms:(4S)-(1-benzyloxycarbonyl)-3-tert-butoxycarbonyl-4-(2-hydroxyethyl)imidazolidine

Suppliers and Price of (4S)-(1-benzyloxycarbonyl)-3-tert-butoxycarbonyl-4-(2-hydroxyethyl)imidazolidine

Supply Marketing:

Business phase:: The product has achieved commercial mass production^*data from LookChem market partment

Manufacturers and distributors:

Manufacture/Brand
Chemicals and raw materials
Packaging
price

Total 0 raw suppliers

Chemical Property of (4S)-(1-benzyloxycarbonyl)-3-tert-butoxycarbonyl-4-(2-hydroxyethyl)imidazolidine

Chemical Property:

Purity/Quality:

Safty Information:

Pictogram(s):
Hazard Codes:

MSDS Files:

Useful:

Technology Process of (4S)-(1-benzyloxycarbonyl)-3-tert-butoxycarbonyl-4-(2-hydroxyethyl)imidazolidine

There total 1 articles about (4S)-(1-benzyloxycarbonyl)-3-tert-butoxycarbonyl-4-(2-hydroxyethyl)imidazolidine which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:

Reference yield: 31.0%

: 1000806-55-2
(E)-4-[(N-tert-butoxycarbonylaminomethyl)-N-benzyloxycarbonylamino]-2-butenal

: 1000806-63-2
(4S)-(1-benzyloxycarbonyl)-3-tert-butoxycarbonyl-4-(2-hydroxyethyl)imidazolidine

Guidance literature:: (E)-4-[(N-tert-butoxycarbonylaminomethyl)-N-benzyloxycarbonylamino]-2-butenal; With benzoic acid; In chloroform; at -40 - 0 ℃; for 72h;

With sodium tetrahydroborate; In methanol; chloroform; at 0 ℃; for 0.5h; Further stages.;
DOI:10.1021/ol702447y